Author

Alex Stratigos

National and Kapodistrian University of Athens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:fine-mapping· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Approach:machine learning (classical)· 1 Research Focus:polygenic risk· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Belynda D. HicksiD· 2 shared Jung KimiD· 2 shared Mai XuiD· 2 shared Michael R. SargeniD· 2 shared Nicholas K. HaywardiD· 2 shared Tongwu ZhangiD· 2 shared Aidan O’BrieniD· 1 shared Alan R. SandersiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Belynda D. HicksORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Melanoma germline genetics: immune, cancer driver, and Wnt signaling genes

G J M Shanika R Jayasinghe, Jianxin Shi, Rohit Thakur, Rebecca Ivy Hartman, Huanwei Wang, Phuc H. Hoang, Daniel R. Dochtermann, Samuel Anyaso-Samuel, Mathias Seviiri, Quan Hoang Nguyen, P. Prakrithi, Thi-Van-Trinh Tran, Xiaoyu Wang, Mai Xu, Xing Hua, , Nhan Do

This paper identifies 116 risk loci for melanoma through GWAS, links susceptibility to immunity and Wnt signaling, and develops a PRS improving risk prediction.

medRxiv · Oct 15, 2026 · PreprintGenetic & Genomic Medicine

Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family

Kevin M. Brown, Mai Xu, Michael R. Sargen, Hyunbum Jang, Mingzhen Zhang, Tongwu Zhang, Bin Zhu, Kristie Jones, Jung Kim, Laura Mendoza, Nicholas K. Hayward, Margaret Anne Tucker, Alisa M. Goldstein, Xiaohong Rose Yang, Douglas R. Stewart, , Maria Teresa Landi

The paper identifies a novel NRAS variant in a melanoma-prone family and shows it impairs MAPK/AKT signaling while enhancing PI3K signaling.

Familial Cancer · Jul 2, 2021Peer-reviewedGenetic & Genomic Medicine